HLA-A and COVID-19: We found that HLA-A*03:01 was significantly associated with systemic side effects (OR = 1.36, CI = 1.31–1.41, p = 6.79×10–57) and fewer breakthrough infections, and that this phenomenon is specific to the COVID-19 vaccine.